Fewer HOT FLASHES and more NOT FLASHES

with 100% hormone-free VEOZAH (fezolinetant).

VEOZAH is a prescription treatment for moderate to severe VMS (Vasomotor Symptoms; the medical name for hot flashes and night sweats) due to menopause.

Two women standing together
Money savings icon

Looking for savings or support in accessing your VEOZAH prescription?

Arrow down icon and “hot flashes” text

VEOZAH is proven to reduce the number and severity of hot flashes, day and night.*

How are hot flashes and night sweats impacting you?

 

*Based on clinical studies measuring efficacy at 4 and 12 weeks.

Icon: Calendar

VEOZAH can reduce hot flashes and night sweats in as early as one week.

 

Individual results may vary. Talk to your healthcare provider about what this may mean for you.

             

The first FDA-approved prescription treatment to directly block a source of hot flashes and night sweats

VEOZAH blocks the binding of NKB, a brain chemical known to trigger hot flashes.

VEOZAH is a prescription treatment designed to help women have fewer hot flashes and more not flashes. So, what are "not flashes"? "Not flashes" are fewer hot flashes and night sweats, which you may experience when taking VEOZAH.§

VEOZAH:

  • is proven to reduce the number and severity of day and night hot flashes§
  • can start working in as early as one week for some women

§Based on clinical studies measuring efficacy at 4 and 12 weeks.


Individual results may vary. Talk to your healthcare provider about what this may mean for you.

Dr. Jen Ashton, Board-Certified OBGYN
Dr. Jen Ashton, Board-Certified OBGYN

Tips From Dr. Jen Ashton

Dr. Jen Ashton shares her perspective

Dr. Jen Ashton, a board-certified OBGYN, shares expert insights on hot flashes due to menopause in this video series.

Dr. Jen Ashton has been compensated by Astellas.

      

Real Pathience

Real VEOZAH Stories

Welcome to The VEOZAH Hot Seat

Three women get in The VEOZAH Hot Seat to share how they’ve been managing their hot flashes and night sweats, night and day.

Erica is a real VEOZAH patient who has been compensated by Astellas

Erica, a real VEOZAH™ patient, tells her story

      

Telehealth phone call

Connect with Telehealth

Get care now

Schedule an appointment to speak to a healthcare provider about your hot flashes and night sweats.

           

           

You could get your first month’s prescription
at
no cost.#

Plus, you could pay as little as $30 for future monthly prescriptions.#||

VEOZAH savings card

Sign up and you could save with the VEOZAH Savings Program.#

For commercially insured patients. Eligibility criteria, terms, and conditions apply. The program is not valid for patients whose prescription claims are reimbursed by any state or federal government program (eg, Medicare, Medicaid). Astellas reserves the right to revoke, rescind, or amend this offer without notice for any reason.


||Subject to an annual maximum copay assistance limit up to $4,000 per calendar year.

           

Stay connected. Sign up for updates.

Look forward to information on:

  • What to expect with VEOZAH      
  • How to stay on track with treatment    
  • Simple tips to help you stay cool     
  • Support every step of the way    

           

What is VEOZAH™ (fezolinetant)?


VEOZAH is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. VEOZAH is not a hormone. Vasomotor symptoms are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating (“hot flashes” or “hot flushes”). 

VEOZAH can cause serious side effects, including:

  • Liver Problems. Your healthcare provider will do a blood test to check your liver before you start taking VEOZAH. Your healthcare provider will also do this blood test monthly for the first 3 months, at month 6, and month 9 after you start taking VEOZAH or if you have signs or symptoms that suggest liver problems. If your liver blood test values are elevated, your healthcare provider may advise you to stop treatment or request additional liver blood tests.

Stop VEOZAH right away and call your healthcare provider if you have the following signs or symptoms of liver problems:

  • feeling more tired than you do usually
  • decreased appetite
  • nausea
  • vomiting
  • itching
  • yellowing of the eyes or skin (jaundice)
  • pale feces
  • dark urine
  • pain in the stomach (abdomen)

Do not use VEOZAH if you:

  • have cirrhosis.
  • have severe kidney problems or kidney failure.
  • are taking certain medicines called CYP1A2 inhibitors. Ask your healthcare provider if you are not sure.

Before you use VEOZAH, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver disease or problems.
  • have kidney problems.
  • have any medical conditions that may become worse while you are using VEOZAH.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VEOZAH may affect the way other medicines work, and other medicines may affect how VEOZAH works.

The most common side effects of VEOZAH include:

  • stomach (abdominal) pain 
  • diarrhea
  • difficulty sleeping (insomnia) 
  • back pain
  • hot flashes or hot flushes 

These are not all the possible side effects of VEOZAH. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

Please see full Prescribing Information and Patient Information, including BOXED WARNING.

What is VEOZAH™ (fezolinetant)?


VEOZAH is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. VEOZAH is not a hormone. Vasomotor symptoms are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating (“hot flashes” or “hot flushes”). 

VEOZAH can cause serious side effects, including:

  • Liver Problems. Your healthcare provider will do a blood test to check your liver before you start taking VEOZAH. Your healthcare provider will also do this blood test monthly for the first 3 months, at month 6, and month 9 after you start taking VEOZAH or if you have signs or symptoms that suggest liver problems. If your liver blood test values are elevated, your healthcare provider may advise you to stop treatment or request additional liver blood tests.

Stop VEOZAH right away and call your healthcare provider if you have the following signs or symptoms of liver problems:

  • feeling more tired than you do usually
  • decreased appetite
  • nausea
  • vomiting
  • itching
  • yellowing of the eyes or skin (jaundice)
  • pale feces
  • dark urine
  • pain in the stomach (abdomen)

Do not use VEOZAH if you:

  • have cirrhosis.
  • have severe kidney problems or kidney failure.
  • are taking certain medicines called CYP1A2 inhibitors. Ask your healthcare provider if you are not sure.

Before you use VEOZAH, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver disease or problems.
  • have kidney problems.
  • have any medical conditions that may become worse while you are using VEOZAH.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VEOZAH may affect the way other medicines work, and other medicines may affect how VEOZAH works.

The most common side effects of VEOZAH include:

  • stomach (abdominal) pain 
  • diarrhea
  • difficulty sleeping (insomnia) 
  • back pain
  • hot flashes or hot flushes 

These are not all the possible side effects of VEOZAH. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

Please see full Prescribing Information and Patient Information, including BOXED WARNING.